The objective of the Fund is to invest in a balanced portfolio of early-stage life science businesses, helping to create and grow some exciting, innovative and potentially life changing companies. The businesses the Fund invests in may have an impact on their local economy, providing highly skilled jobs and further increasing the overall strength of the UK life sciences sector.
Investment has been made in the following companies since the funds inception in Q2 2022.
